PMDA-2022-0043-V443

Type II variation for application PMDA-2022-0043. Type II variation: Facility Change for Upadacitimab — routine update

Variation Number
PMDA-2022-0043-V443
Type
Type II
Application
PMDA-2022-0043
Change
CHG-2022-0143
Status
Approved
Fee
€65,553
Submitted
—
Approved
2024-01-25
Description

Type II variation: Facility Change for Upadacitimab — routine update